v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (9,137,586) $ (7,514,138)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Stock based compensation 2,780,474 4,380,679
Non-cash marketing expense for stock issued to vendor 151,128
Amortization of debt discount and debt issuance costs 692,710
Change in fair value of common stock make-whole obligation 53,629 215,443
Loss on sale of investments in equity securities 95,178
Change in fair value of investment in equity securities 8,572 728,134
Loss on extinguishment of liability, net 122,409
Loss on write-off of promissory note and deposit 232,481
Deferred transaction cost expensed 25,000 30,000
Change in fair value of warrant liability 115,782 (2,171,692)
Change in fair value of sponsor earnout shares (528,000)
Depreciation expense 2,566 1,536
Amortization of operating lease right-of-use asset 15,810
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 12,701 239,723
Accounts payable 487,156 128,902
Accrued liabilities and other liabilities 682,807 (328,696)
Operating right of use asset and liability (15,810)
Net cash used in operating activities (4,002,652) (4,490,450)
Cash flows from investing activities:    
Capital project costs (175,644) (2,278,760)
Land acquisition cost (16,619)
Proceeds from sale of investment in equity securities 78,311
Purchase of computer and equipment (18,668)
Net cash used in investing activities (194,312) (2,217,068)
Cash flows from financing activities:    
Proceeds from issuance of common stock 1,512,480 122,551
Proceeds from issuance of notes payable to related parties 250,000
Repayment of notes payable to related parties (250,000)
Repayment of short-term loan from related parties (2,000,000)
Repayment of short-term loan (205,403) (1,808,552)
Proceeds from advance received from PIPE investors 125,000
Deferred transaction costs paid (50,000) (25,000)
Proceeds from public offerings 10,270,400
Proceeds from warrant inducement exercises 2,971,040
Transaction costs associated with public offerings and warrant inducement (1,252,152)
Repurchase of unvested shares (1,593)
Net cash provided by financing activities 1,257,077 8,401,694
Net (decrease)/ increase in cash (2,939,887) 1,694,176
Cash at the beginning of the period 3,480,151 912,574
Cash at the end of the period 540,264 2,606,750
Supplemental disclosure for cash flow information:    
Interest paid 40,684 143,565
Taxes paid 2,650 5,150
Supplemental disclosure of non-cash investing and financing activities:    
Unpaid capital project costs 112,514 1,698,517
Unpaid property and equipment purchase cost 9,132
Fair value of common stock issued to settle accrued bonus 1,573,032
Operating right of use asset obtained in exchange for new lease liability 173,254
Common stock issued for partial repayment of 2025 convertible note 847,381
Unpaid at-the-market offering costs 57,875
Reclass of advances to capital project costs 236,235
Unpaid public offering issuance cost 623,345
Unpaid warrant inducement issuance cost 29,000
Incremental fair value of warrant inducement 2,108,480
Issuance of common stock to short- term loan holders 6,200,000
Issuance of common stock to PIPE investors 550,000
Issuance of common stock to vendor 80,612
Issuance of common stock under license arrangement $ 343,000